Premium
NK‐3 receptors mediate enhancement of substance P release from capsaicin‐sensitive spinal cord afferent terminals
Author(s) -
Schmid Giovanna,
Carità Francesca,
Bonanno Giambattista,
Raiteri Maurizio
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702093
Subject(s) - capsaicin , substance p , receptor , endocrinology , medicine , neurokinin b , chemistry , antagonist , receptor antagonist , spinal cord , tachykinin receptor , neuropeptide , biology , neuroscience
1 The effects of NK‐3 receptor agonists on the release of substance P‐immunoreactivity (SP‐LI) have been investigated using superfused rat spinal cord synaptosomes. 2 The Ca 2+ ‐dependent overflow of SP‐LI evoked by 35 m M KCl was concentration‐dependently enhanced by senktide (EC 50 =52 n M ; maximal effect=70%) or [MePhe 7 ]NKB (EC 50 =5.5 n M ; maximal effect=125%), both selective agonists at receptors of the NK‐3 type. 3 The potentiation of the SP‐LI overflow elicited by 100 n M senktide or [MePhe 7 ]NKB was prevented by the NK‐3 receptor antagonist (+)‐SR142801. The antagonist halved, at 10 n M , and almost abolished, at 100 n M , the effect of both agonists. The effect of senktide or [MePhe 7 ]NKB was insensitive to antagonists at NK‐1 or NK‐2 receptors. 4 Capsaicin (0.1–1 μ M ) stimulated SP‐LI release in a concentration‐dependent manner from spinal cord synaptosomes. The SP‐LI overflow elicited by 1 μ M capsaicin was completely dependent on external Ca 2+ . Senktide could not affect the capsaicin‐evoked release of SP‐LI. 5 Senktide failed to potentiate the K + ‐evoked overflow of SP‐LI from synaptosomes previously exposed for 15 min in superfusion to capsaicin. 6 The results show that release‐enhancing NK‐3 receptors are located on axon terminals of capsaicin‐sensitive primary afferent neurones in the spinal cord. Antagonists at NK‐3 receptors might help controlling pain transmission.British Journal of Pharmacology (1998) 125 , 621–626; doi: 10.1038/sj.bjp.0702093